Bjermer, L. (Contributor), van Boven, J. F. M. (Contributor), Costa-Scharplatz, M. (Contributor), Keininger, D. L. (Contributor), Gutzwiller, F. S. (Contributor), Lisspers, K. (Contributor), Mahon, R. (Contributor), Olsson, P. (Contributor), Roche, N. (Contributor) (
11-dec.-2017). Additional file 1: of Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population. University of Groningen.
10.6084/m9.figshare.5691691.v1